{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:52:17Z","timestamp":1787935937802,"version":"build-2784847793"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Family Med Prim Care"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jfmpc.jfmpc_825_19","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T05:33:45Z","timestamp":1575869625000},"page":"3783","source":"Crossref","is-referenced-by-count":13,"title":["The role of bisphosphonates in orthodontic tooth movement\u2014A review"],"prefix":"10.4103","volume":"8","author":[{"given":"Nancy","family":"Ajwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2249-4863.272504-1","doi-asserted-by":"crossref","unstructured":"Kaplia S, King GJ. Biological mechanisms in orthodontic tooth movement. In: Nanda R, editor. Esthetic and Biomechanics in Orthodontics. St. Louis, Missouri: Elsevier; 2015. p. 90-107.","DOI":"10.1016\/B978-1-4557-5085-6.00005-9"},{"key":"key-10.4103\/2249-4863.272504-2","first-page":"ZE01","article-title":"Effect of bisphosphonates on orthodontic tooth movement-an update","author":"Krishnan","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/2249-4863.272504-3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1746-160X-9-10","article-title":"Current state of orthodontic patients under bisphosphonate therapy","author":"Krieger","year":"2013","journal-title":"Head Face Med"},{"key":"key-10.4103\/2249-4863.272504-4","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","article-title":"The Pathophysiology and treatment of osteoporosis","author":"Drake","year":"2015","journal-title":"Clin Ther"},{"key":"key-10.4103\/2249-4863.272504-5","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-0501.2009.01772.x","article-title":"What impact do systemically administered bisphosphonates have on oral implant therapy.A systematic review?","author":"Madrid","year":"2009","journal-title":"Clin Oral Implants Res"},{"key":"key-10.4103\/2249-4863.272504-6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1708-8208.2009.00150.x","article-title":"Implant placement in patients with oral bisphosphonate therapy: A case series","author":"Shabestari","year":"2010","journal-title":"Clin Implant Dent Relat Res"},{"key":"key-10.4103\/2249-4863.272504-7","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: Mode of action and pharmacology","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"key":"key-10.4103\/2249-4863.272504-8","unstructured":"National Institute for Health and Care Excellence. Multimorbidity: Clinical assessment and management. NICE guideline NG56, 2016. Nice.org.uk."},{"key":"key-10.4103\/2249-4863.272504-9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcb.25266","article-title":"Risks and benefits of bisphosphonate therapies","author":"Reyes","year":"2016","journal-title":"J Cell Biochem"},{"key":"key-10.4103\/2249-4863.272504-10","first-page":"379","article-title":"Drugs for the management of osteoporosis: A review","author":"Khajuria","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"key-10.4103\/2249-4863.272504-11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: Medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"key-10.4103\/2249-4863.272504-12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","author":"Compston","year":"2017","journal-title":"Arch Osteoporos"},{"key":"key-10.4103\/2249-4863.272504-13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","author":"Fleisch","year":"1966","journal-title":"Nature"},{"key":"key-10.4103\/2249-4863.272504-14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.15537\/smj.2018.3.20923","article-title":"Clinical impact of bisphosphonates in root canal therapy","author":"AlRahabi","year":"2018","journal-title":"Saudi Med J"},{"key":"key-10.4103\/2249-4863.272504-15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday","author":"McClung","year":"2013","journal-title":"Am J Med"},{"key":"key-10.4103\/2249-4863.272504-16","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00198-017-3992-5","article-title":"Factors associated with acute-phase response of bisphosphonate- na\u00efve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate","author":"Popp","year":"2017","journal-title":"Osteoporos Int"},{"key":"key-10.4103\/2249-4863.272504-17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2013.01.032","article-title":"Biomedical applications of bisphosphonates","author":"Giger","year":"2013","journal-title":"J Control Release"},{"key":"key-10.4103\/2249-4863.272504-18","first-page":"831","article-title":"Bisphosphonates: How do they work?","author":"Papapoulos","year":"38;","journal-title":"Best practice"},{"key":"key-10.4103\/2249-4863.272504-19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ejo\/26.5.469","article-title":"Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats","author":"Liu","year":"2004","journal-title":"Eur J Orthod"},{"key":"key-10.4103\/2249-4863.272504-20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1177\/00220345940730081301","article-title":"Effects of topical administration of a bisphosphonate (Risedronate) on orthodontic tooth movements in rats","author":"Adachi","year":"1994","journal-title":"J Dent Res"},{"key":"key-10.4103\/2249-4863.272504-21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0722.2007.00433.x","article-title":"Inhibition of tooth movement by osteoprotegerin vs.pamidronate under conditions of constant orthodontic force","author":"Keles","year":"2007","journal-title":"Eur J Oral Sci"},{"key":"key-10.4103\/2249-4863.272504-22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajodo.2012.05.019","article-title":"Bisphosphonates as a risk factor for adverse orthodontic outcomes: A retrospective cohort study","author":"Lotwala","year":"2012","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"key-10.4103\/2249-4863.272504-23","first-page":"1644","article-title":"Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats","author":"Igarashi","year":"1996","journal-title":"J Dent Res"},{"key":"key-10.4103\/2249-4863.272504-24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0889-5406(99)70290-8","article-title":"An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars","author":"Kim","year":"1999","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"key-10.4103\/2249-4863.272504-25","first-page":"2","article-title":"American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2249-4863.272504-26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1097-0185(20000901)260:1<72::AID-AR80>3.0.CO;2-2","article-title":"Bisphosphonate administration alters subcellular localization of vacuolar-type H+-ATPase and cathepsin K in osteoclasts during experimental movement of rat molars","author":"Sato","year":"2000","journal-title":"Anat Rec"},{"key":"key-10.4103\/2249-4863.272504-27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/154405910608500813","article-title":"Clodronate inhibits PGE (2) production in compressed periodontal ligament cells","author":"Liu","year":"2006","journal-title":"J Dent Res"},{"key":"key-10.4103\/2249-4863.272504-28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0889-5406(87)90367-2","article-title":"The morphologic and biochemical effects of tensile force to the interparietal suture of the Spraque-Dawley rat","author":"Miyawaki","year":"1987","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"key-10.4103\/2249-4863.272504-29","first-page":"622","article-title":"Sutural development: Structure and its response to rapid expansion","author":"Ten","year":"1977","journal-title":"Am J Orthod"},{"key":"key-10.4103\/2249-4863.272504-30","first-page":"371","article-title":"Rapid palatal expansion: Part 1.Mineralization pattern of the midpalatal suture in cats","author":"Vardimon","year":"1998","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"key-10.4103\/2249-4863.272504-31","doi-asserted-by":"crossref","unstructured":"Jachewicz TK, Jakiel J. Bone necrosis associated with the use of bisphosphonates: Case report Dent Med Probl 2017;54:297-302.","DOI":"10.17219\/dmp\/74884"},{"key":"key-10.4103\/2249-4863.272504-32","doi-asserted-by":"crossref","first-page":"e007133","DOI":"10.1136\/bmjopen-2014-007133","article-title":"Bisphosphonates and evidence for association with esophageal and gastric cancer: A systematic review and meta-analysis","author":"Wright","year":"2015","journal-title":"BMJ Open"},{"key":"key-10.4103\/2249-4863.272504-33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International task force on osteonecrosis of the jaw.Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/2249-4863.272504-34","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"American society for bone and mineral research.Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American society for bone and mineral research","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/2249-4863.272504-35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.Fracture Intervention Trial Research Group","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"key-10.4103\/2249-4863.272504-36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily, and intermittent oral Ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: Results from the BONE study","author":"Delmas","year":"2004","journal-title":"Osteoporos Int"},{"key":"key-10.4103\/2249-4863.272504-37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Oral ibandronate osteoporosis vertebral fracture trial in North America and Europe (BONE).Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/2249-4863.272504-38","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"HORIZON Pivotal Fracture Trial.Once yearly zoledronic acid for treatment of postmenopausal osteoporosis","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2249-4863.272504-39","first-page":"nihpa40967","article-title":"for the HORIZON recurrent fracture trial.Zoledronic acid in reducing clinical fracture and mortality after hip fracture","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2249-4863.272504-40","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.14219\/jada.archive.2008.0110","article-title":"American dental association council on scientific affairs expert panel on bisphosphonate- associated osteonecrosis of the jaw.Updated recommendation for managing the care of patients receiving oral bisphophonate therapy: An advisory statement from the American dental association council on scientific affairs","author":"Edwards","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"key-10.4103\/2249-4863.272504-41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-5406(94)70048-6","article-title":"Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movement inrats","author":"Igarashi","year":"1994","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"key-10.4103\/2249-4863.272504-42","unstructured":"NOGG. Clinical guideline for the prevention and treatment of osteoporosis: The guideline has been published in Archives of Osteoporosis 2017. Available from http:\/\/link.springer.com\/article\/10.1007\/."},{"key":"key-10.4103\/2249-4863.272504-43","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 2014;72.10:1938-56.","DOI":"10.1016\/j.joms.2014.04.031"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:41:57Z","timestamp":1786732917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_825_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"alternative-id":["272504"],"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_825_19","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}